Compare XTNT & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XTNT | LOAN |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.9M | 47.6M |
| IPO Year | 2009 | 1999 |
| Metric | XTNT | LOAN |
|---|---|---|
| Price | $0.32 | $3.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.03 | N/A |
| AVG Volume (30 Days) | ★ 185.7K | 49.6K |
| Earning Date | 11-09-2026 | 10-23-2026 |
| Dividend Yield | N/A | ★ 12.83% |
| EPS Growth | ★ 125.00 | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | ★ $53,337,000.00 | $8,666,307.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.85 | N/A |
| P/E Ratio | ★ N/A | $16.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.27 | $3.33 |
| 52 Week High | $0.95 | $5.41 |
| Indicator | XTNT | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 39.89 | 22.78 |
| Support Level | $0.32 | N/A |
| Resistance Level | $0.49 | $4.52 |
| Average True Range (ATR) | 0.02 | 0.12 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 11.55 |
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.